On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
WednesdayJan 19, 2022 12:30 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Announces Retention of Investor, PR Partner

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company, has retained Emerging Markets Consulting LLC (“EMC”) to provide investor and public relations services. SPYR’s subsidiary, Applied Magix Inc., develops and resells Apple(R) ecosystem-compatible products in the growing multibillion-dollar IoT smart-home and connected car markets. According to the announcement, EMC specializes in assisting small and mid-sized public companies strengthen their brands and grow market share while also increasing awareness among the institutional and retail investment community. “After meeting their talented team, I am excited to be working with EMC," said SPYR Technologies CEO Tim Matula in the press release. “EMC's representation will…

Continue Reading

WednesdayJan 19, 2022 12:09 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Rare Cannabinoid Product Portfolio to Launch CBT

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced that it has launched B2B sales of the rare cannabinoid cannabicitran (“CBT”) into the health and wellness sector. According to the update, CBT is the first of several new product launches the company has planned for the first half of 2022. “We are delivering on our objective to launch additional rare cannabinoids in early 2022 in response to inbound demand. By midyear, we expect to have at least four rare cannabinoids available for the health and wellness markets, positioning us as a…

Continue Reading

WednesdayJan 19, 2022 12:00 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Announces New Details Regarding Its Strategic Acquisition

Friendable (OTC: FDBL), a mobile technology and marketing company, today released additional details relating to its recent acquisition of music distribution company Artist Republik. Following the development and growth of Friendable’s livestream artist offering, management identified expansion opportunities in the music distribution and services sector, which are services that truly allow artists, most often independent artists, to be heard. The Fan Pass Live platform acts as the artist’s label or manager, in a sense, by providing these unique services and managing all that comes with them. “Artist Republik has experienced great momentum in music distribution,” said Friendable CEO Robert A.…

Continue Reading

WednesdayJan 19, 2022 11:11 am

QualityStocksNewsBreaks – Kronos Advanced Technologies Inc. (KNOS) Files Registration Statement to Fund Expansion up to $10M

Kronos Advanced Technologies (OTC: KNOS), a revenue-generating product development and production company that has significantly changed the way air is moved, filtered and disinfected, announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) for a proposed offering of its shares. According to the update, KNOS entered into a common stock purchase agreement with Dutchess Capital Growth Fund LP to raise up to $10,000,000 via an equity financing facility. Kronos will use the funds raised to complete renovation of its electronic manufacturing facility, purchase advanced robotic automated manufacturing assembly lines, and…

Continue Reading

TuesdayJan 18, 2022 4:08 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Provides Comments Regarding Study Examining Cannabinoids and SARS-CoV-2

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has commented on a recent study that indicated that cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2. The comments came from lead research scientist Dr. Richard van Breeman, who granted an interview with vice.com discussing the independent study. In his comments, Breemen observed that smoking or vaping of cannabis was likely not effective, but oral delivery was, causing Breeman to recommend oral administration of cannabis compounds. Lexaria is keenly interested in the study because the company is actively engaged in research with its exclusive DehydraTECH(TM)-powered cannabinoid formulations,…

Continue Reading

TuesdayJan 18, 2022 3:33 pm

QualityStocksNewsBreaks – Growth Capital Acquisition Corp.’s (NASDAQ: GCAC) Pending Business Combination Partner to Present at Baird 2022 Conference

Growth Capital Acquisition Corp. (NASDAQ: GCAC) and its wholly owned subsidiary, GCAC Merger Sub Inc., previously entered into a business combination agreement with Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance MMT(R) lidar solutions. Cepton today announced that its CEO Dr. Jun Pei and CFO Dr. Winston Fu will present virtually in the Baird 2022 Vehicle Technology and Mobility Conference at 1:10 p.m. ET on Tuesday, Jan. 25, 2022. According to the update, a link to the live webcast of management’s presentation along with additional investor materials and company information can be found on the investor…

Continue Reading

TuesdayJan 18, 2022 3:25 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Q3 2022 Financial Results

FingerMotion (NASDAQ: FNGR), a mobile data and services company, is reporting financial results for the third quarter, the period ended Nov. 30, 2021. Highlights of the report include quarterly revenue of $5.9 million, an increase of $1.02 million or 21% over Q3 2020; year-over-year quarterly growth in its telecommunications products & services business revenue of $2.8 million, a 580% increase over Q3 2020; quarterly loss in SMS & MMS business revenue of $1.78 million, or 40% compared to the same period in 2020; and no revenues in its big data division. In addition, the company showed gross profits of $967,075,…

Continue Reading

TuesdayJan 18, 2022 2:45 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Q4 Shares Repurchased, 1st Dividend Payment

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced the quantity of shares repurchased in the fourth quarter of 2021, as well as the first payment being made for the previously issued dividend. According to the update, the company repurchased approximately $800K worth of stock made up of 155,000 shares of common stock at an average price of $5.12 per share throughout the three months preceding Dec. 31, 2021. This was part of SRAX’s $10 million share buyback program announced on Aug. 17, 2021. “We…

Continue Reading

TuesdayJan 18, 2022 2:39 pm

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Releases Results of Harris Survey on Psychedelics as an Alternative Treatment

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has announced that nearly two-thirds (65%) of Americans who suffer from anxiety, depression and PTSD believe that psychedelic medicine, including ketamine, psilocybin and MDMA, should be available to patients with treatment-resistant anxiety, depression or PTSD. The online survey included 953 adults living in the United States who suffer from anxiety, depression or PTSD. Of those surveyed, 63% of those who have used prescription medications for treatment response that, while the medication helped, they still experienced residual feelings of anxiety, depression or…

Continue Reading

TuesdayJan 18, 2022 2:10 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), The Newly Partner to Set the Gold Standard for Psychedelic-Assisted Therapies

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today announced its entry into a letter of intent (“LOI”) with The Newly Institute Inc. (“The Newly”), a Calgary, Alberta based company opening private inter-disciplinary mental health clinics across Canada. The companies will collaborate on expanding psychedelic-assisted psychotherapy to patients and, together, create the package of resources needed for patients and practitioners to successfully gain acceptance into Health Canada's Special Access Program (“SAP”). The Newly is the first partner under Mydecine's recently announced Special Access Support…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered